Upgrade to SI Premium - Free Trial

Enzo Biochem (ENZ) Assigned U.S. Patent '090 Covering Construction of Artificial Vector

June 6, 2014 8:38 AM
Enzo Biochem (NYSE: ENZ) has been assigned U.S. Patent Office Patent No. 8,742,090, related to the construct of an artificial ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Litigation Management Comments

Next Articles